Immunology and Bi...
Follow
3.6K views | +3 today
Scooped by Gilbert Faure au nom de l'ASSIM
onto Immunology and Biotherapies
Scoop.it!

Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model - Alaee - 2013 - Journal of Orthopaedic Research - Wiley Online ...

Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model - Alaee - 2013 - Journal of Orthopaedic Research - Wiley Online ... | Immunology and Biotherapies | Scoop.it
Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat fe... http://t.co/cnqYdwLMeQ
more...
No comment yet.
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Resources for DIU Immunologie et Biothérapies

DIU Immunologie et Biotherapies is a french diploma associating many french universities and immunology laboratories. It is dedicated to the involvement of immunology in new biotherapies, either molecular or cellular

Gilbert Faure au nom de l'ASSIM's insight:

We choose Scoop.it as the best curation tool to collect, select, comment informations flowing on the web in this rapidly evolving theme to keep teachers abreast of scientific knowledge and help students surf the wave...

Feel free to be a follower!

 

If you are interested

in Immunology also use http://www.scoop.it/t/immunology

in Mucosal Immunity http://www.scoop.it/t/mucosal-immunity

in Flow Cytometry and Cytomics http://www.scoop.it/t/from-flow-cytometry-to-cytomics

in Allergy an Clinical Immunology http://www.scoop.it/t/allergy-and-clinical-immunology

in Autoimmunity http://www.scoop.it/t/autoimmunity

 

For further informantions on Immune monitoring of Immune therapies, go to

http://www.scoop.it/t/immune-monitoring-1

by MdC

 

Looking for cancer applications inside this topic, use

http://www.scoop.it/t/immunology-and-biotherapies?q=cancer

 

more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Monoclonal Antibodies Key to Unlocking the Biosimilars Market - The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth. - Bi

Monoclonal Antibodies Key to Unlocking the Biosimilars Market - The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth. - Bi | Immunology and Biotherapies | Scoop.it
The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth. (Approval/acceptance of monoclonal antibody biosimilars is necessary for biosimilars market to experience real growth.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

BMS Partners Again with Ambrx, in Up-to-$112M-and-Up ADC Collaboration

BMS Partners Again with Ambrx, in Up-to-$112M-and-Up ADC Collaboration | Immunology and Biotherapies | Scoop.it
Bristol-Myers Squibb (BMS) will use Ambrx’s protein medicinal technology to develop antibody drug conjugates (ADCs) for unspecified cancer indications, in an up-to-$112 million-and-up collaboration that is the third between the companies.-- Delivered...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Next-Gen Antibody Therapies 2014 ← visiongain blog

Next-Gen Antibody Therapies 2014 ← visiongain blog | Immunology and Biotherapies | Scoop.it
[Blog Entry] Next-generation antibody therapies will grow by 90% in 2014 http://t.co/wfMiebhel5
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Live Viral Vaccines in Immunocompromised Patients

Live Viral Vaccines in Immunocompromised Patients | Immunology and Biotherapies | Scoop.it
Live viral vaccines may be safe for immunocompromised patients under certain specific circumstances.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

ADC Review / Journal of Antibody-drug Conjugates

ADC Review / Journal of Antibody-drug Conjugates | Immunology and Biotherapies | Scoop.it
The Journal reviews and discusses the ongoing clinical research, development and production associated with Antibody-drug Conjugates.
Gilbert Faure au nom de l'ASSIM's insight:

un journal spécifique

more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Co-stimulatory blockade with belatacept in kidney transplantation, Expert Opinion on Biological Therapy, Informa Healthcare

Co-stimulatory blockade with belatacept in kidney transplantation, Expert Opinion on Biological Therapy, Informa Healthcare | Immunology and Biotherapies | Scoop.it
FREE editorial on Belatacept, promising kidney transplantation drug, read it now here – http://t.co/rG2vBuStW7
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin ... - Science Codex

Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin ... - Science Codex | Immunology and Biotherapies | Scoop.it
Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin ...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies

A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies - up-to-the-minute news and headlines.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Enhancement of antitumor immunity by combining ant... [Oncol Rep. 2013] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM from Cancer Immunotherapy Review
Scoop.it!

The Scientist Magazine Explains the Science of Immunotherapy

The Scientist Magazine Explains the Science of Immunotherapy | Immunology and Biotherapies | Scoop.it
A recent high-profile article introduces readers to the science behind cancer immunotherapy. (RT @CancerResearch: Need a quick introduction to the field of cancer #Immunotherapy?

Via Krishan Maggon
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Herceptin could face biosimilars in UK later this year - PMLiVE

Herceptin could face biosimilars in UK later this year - PMLiVE | Immunology and Biotherapies | Scoop.it
Herceptin could face biosimilars in UK later this year PMLiVE If that occurs the two companies will have two biosimilar monoclonal antibodies on the market in Europe, having secured approval for Inflectra/Remsima, a copycat version of Johnson &...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Matthew Albert - Egypt needs a hepatitis C vaccine urgently - Youris.com

Matthew Albert - Egypt needs a hepatitis C vaccine urgently - Youris.com | Immunology and Biotherapies | Scoop.it
Matthew Albert - Egypt needs a hepatitis C vaccine urgently Youris.com Project coordinator Matthew Albert is director of the immunology department and director of the laboratory of dendritic cell immunobiology at the Institut Pasteur in Paris,...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

A novel anti-CD19 monoclonal antibody (GBR 4... [J Hematol Oncol. 2014] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Monoclonal Antibody Treatment Shows Promise for Curing Ebola | MIT Technology Review

Monoclonal Antibody Treatment Shows Promise for Curing Ebola | MIT Technology Review | Immunology and Biotherapies | Scoop.it
The virus is tamed in macaques.(RT @novaspivack: Monoclonal Antibody Treatment Shows Promise for Curing Ebola | MIT http://t.co/PVVKbiCGUF And here's ANOTHER approach #eb…)...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

BTS 2014 Report: HLA-incompatible transplantation « Medical Update Online

BTS 2014 Report: HLA-incompatible transplantation « Medical Update Online | Immunology and Biotherapies | Scoop.it
HLA-incompatible #transplantation « Medical Update Online: http://t.co/b1oJ6Py9Jb
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Immunotoxin Therapy for Relapsed Hairy Cell Leukemia - National Cancer Institute

Immunotoxin Therapy for Relapsed Hairy Cell Leukemia - National Cancer Institute | Immunology and Biotherapies | Scoop.it
In this trial, patients with hairy cell leukemia who have relapsed multiple times or not responded to prior chemotherapy will be treated with an experimental immunotoxin called moxetumomab pasudotox given intravenously on days 1, 3, and 5 of 28-day...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Development of Safe and Effective RSV Vaccine by Modified CD4 Epitope in G Protein Core Fragment (Gcf)

Development of Safe and Effective RSV Vaccine by Modified CD4 Epitope in G Protein Core Fragment (Gcf) | Immunology and Biotherapies | Scoop.it
by In Su Cheon, Byoung-Shik Shim, Sung-Moo Park, Youngjoo Choi, Ji Eun Jang, Dae Im Jung, Jae-Ouk Kim, Jun Chang, Cheol-Heui Yun, Man Ki Song Respiratory syncytial virus (RSV) is a major cause of respiratory tract infection in infants and young...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Immune Pharma Tackling Orphan Disease Bullous Pemphigoid - Seeking Alpha

Immune Pharma Tackling Orphan Disease Bullous Pemphigoid - Seeking Alpha | Immunology and Biotherapies | Scoop.it
Immune Pharma Tackling Orphan Disease Bullous Pemphigoid Seeking Alpha We believe that the lack of efficacy noted for CAT-213 is likely due to no selection criteria for patients with diseases associated with increased eotaxin-1 levels and is not...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

USDA Approves New Combination Vaccine To Fight BRD Viruses And Bacteria - Beef Magazine

USDA Approves New Combination Vaccine To Fight BRD Viruses And Bacteria
Beef Magazine
Bovine viral diarrhea virus type 1- and type 2-specific bovine T lymphocyte-subset responses following modified-live virus vaccination.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Monoclonal antibody pinpoints BRAF status in melanoma : IMNG Oncology Report

Monoclonal antibody pinpoints BRAF status in melanoma : IMNG Oncology Report | Immunology and Biotherapies | Scoop.it
DENVER - A murine monoclonal antibody had very high sensitivity and specificity for melanomas with the V600E BRAF mutation, and exhibited perfect concordance between the primary and metastatic tumors in individual patients.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Long-Term Outcomes from Cytori Cell Therapy Trial for Heart Failure Published in American Heart Journal

Long-Term Outcomes from Cytori Cell Therapy Trial for Heart Failure Published in American Heart Journal | Immunology and Biotherapies | Scoop.it
From BioPortfolio: PRECISE Data Demonstrate Sustained Safety and Benefit at 18-Months Cytori Therapeutics (NASDAQ: CYTX) today announced publication of safety and efficacy data fr...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM from Immunology and Biotherapies
Scoop.it!

The Story of César Milstein and Monoclonal Antibodies: Introduction

The Story of César Milstein and Monoclonal Antibodies: Introduction | Immunology and Biotherapies | Scoop.it
An online exhibition on Cesar Milstein, Cambridge legend (I came to Cambridge to work with him....) http://t.co/cyVYU76T #immunology

Via Gilbert Faure au nom de l'ASSIM
Gilbert Faure au nom de l'ASSIM's insight:

I scoop.it again!

before my next course on monoclonal antibodies, I have been reading in more details those webpages

the exhibition form the MRC is an extraordinary teaching source on immunology, research processes and scientific history, unknown from most of us

read it again, and again for humility and stimulation

more...
Gilbert Faure au nom de l'ASSIM's curator insight, February 17, 2013 3:29 PM

when you read in their essays what medical students know on the topic, you would think that this exhibition will be a valuable resource!

Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Adipose-Derived Regenerative Cells in Patients with Ischemic Cardiomyopathy: The PRECISE Trial

Adipose-Derived Regenerative Cells in Patients with Ischemic Cardiomyopathy: The PRECISE Trial | Immunology and Biotherapies | Scoop.it
American Heart Journal, Volume null, Issue null, Pages null, null, Authors:Emerson C. Perin, MD PhD; Ricardo Sanz-Ruiz, MD; Pedro L. Sánchez, MD PhD; José Lasso, MD PhD; Rosa Pérez-Cano, MD PhD; Juan C.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells | Immunology and Biotherapies | Scoop.it
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen... http://t.co/6wkBLnO0PE #bloodTCB
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Biomedical Goats Aren't Your Typical Livestock—They Might Save Your Life - TakePart

Biomedical Goats Aren't Your Typical Livestock—They Might Save Your Life - TakePart | Immunology and Biotherapies | Scoop.it
Biomedical Goats Aren't Your Typical Livestock—They Might Save Your Life
TakePart
Monoclonal antibodies work with a sick person's immune system to help the body better fight off disease.
Gilbert Faure au nom de l'ASSIM's insight:

no monoclonal antibodies yet

more...
No comment yet.